Ocythera
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 2
About Ocythera
Ocythera, founded in 2021 and headquartered in Montreal, Canada, focuses on therapies for rare bone disorders. The company has engaged in 1 deal, with its most recent deal occurring on January 29, 2026.Ocythera specializes in developing innovative therapies for rare bone disorders through first-in-class small molecule inhibitors that selectively target enzymes involved in bone disease pathology. The company primarily focuses on Hereditary Multiple Osteochondromas (MO) and Fibrodysplasia Ossificans Progressiva (FOP), which affect bone formation and mobility. Their compounds modulate local retinoic acid signaling pathways, offering a safer therapeutic profile.Ocythera's revenue model is structured around strategic partnerships and collaborations with healthcare providers and research institutions, focusing on rare disease therapeutics. The company is expected to generate revenue through licensing agreements and research collaborations. The company plans to introduce new products focused on these therapies as they advance through clinical trials, while also targeting expansion into new geographic markets in North America and Europe by 2026.
Who invested in Ocythera
2 investors across 1 round
See all investors in Ocythera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 29, 2026
Amount
Undisclosed
Investors
Questions about Ocythera
Who invested in Ocythera?
Ocythera has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ocythera raised?
Ocythera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ocythera last raise money?
Ocythera's most recent round on record is a Seed, in Jan 2026.
What does Ocythera do?
Ocythera, founded in 2021 and headquartered in Montreal, Canada, focuses on therapies for rare bone disorders.
Where is Ocythera headquartered?
Ocythera is headquartered in Montreal, Canada.
Which VCs invest in companies like Ocythera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ocythera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ocythera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.